Real-World Antidepressant Prescribing Patterns and Comparative Safety Outcomes of Commonly Prescribed Antidepressants in Patients with Depressive Disorder: A Multicenter OMOP-CDM Study
Pharmaceuticals · 24.08.2026 · 19 (9) · 1332
DOI: 10.3390/ph19091332 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceuticals, online erschienen am 24.08.2026. Verfasst von Jungha Min und 5 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Ewha Womans University, Seoul 03760, Republic of Korea. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and ICT, Ministry of Education, National Research Foundation of Korea.
Abstract (Originalsprache)
Background/Objectives: Real-world antidepressant use for depressive disorder varies across clinical settings. This study aimed to characterize prescribing pathways and evaluate the comparative safety of frequently prescribed antidepressants in a large multicenter cohort with newly diagnosed depressive disorder.
Methods
We conducted a retrospective multicenter observational study using electronic health record data standardized to the OMOP Common Data Model (1999–2026) in adults initiating antidepressants. Prescribing patterns among 13,381 patients were visualized using sunburst plots and Sankey diagrams. Comparative safety, escitalopram vs. sertraline and trazodone, was evaluated across 18 hospitals (n = 44,542) for nine clinical safety outcomes using propensity score-matched Cox proportional hazards models and empirically calibrated random-effects meta-analysis.
Results
Selective serotonin reuptake inhibitors, particularly escitalopram (21.4%, n = 2868), were the preferred antidepressant. Common adjunctive medications included trazodone (14.6%, n = 794) and quetiapine (14.0%, n = 761), though utilization varied across hospitals. No clear differences were detected for most safety outcomes between cohorts. However, empirically calibrated QTc prolongation risk was significantly increased with sertraline relative to escitalopram (HR 1.75, 95% CI 1.10–2.78), a signal requiring further confirmation.
Conclusions
This study demonstrates substantial institutional variation exists in real-world antidepressant treatment pathways and combination strategies. While comparative safety profiles were broadly comparable across evaluated outcomes, the isolated QTc prolongation signal for sertraline warrants targeted external confirmation. Furthermore, trazodone and escitalopram cohorts should not be regarded as clinically interchangeable first-line options, supporting individualized, evidence-based antidepressant selection in routine clinical practice.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- College of Pharmacy, Ewha Womans University, Seoul 03760, Republic of Korea.
- Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul 03760, Republic of Korea.
ORCID-Profile: Jeongha Yun, Sandy Jeong Rhie
Förderung
- Ministry of Science and ICT
- Ministry of Education
- National Research Foundation of Korea
Zitieren
APA
Min, J., Shin, S., Park, S., Yun, J., Park, K., & Rhie, S. J. (2026). Real-World Antidepressant Prescribing Patterns and Comparative Safety Outcomes of Commonly Prescribed Antidepressants in Patients with Depressive Disorder: A Multicenter OMOP-CDM Study. Pharmaceuticals, 19(9), 1332. https://doi.org/10.3390/ph19091332
Vancouver
Min J, Shin S, Park S, Yun J, Park K, Rhie SJ. Real-World Antidepressant Prescribing Patterns and Comparative Safety Outcomes of Commonly Prescribed Antidepressants in Patients with Depressive Disorder: A Multicenter OMOP-CDM Study. Pharmaceuticals. 2026;19(9):1332. doi:10.3390/ph19091332
BibTeX
@article{Min2026,
author = {Min, Jungha and Shin, Sueun and Park, Sohyeon and Yun, Jeongha and Park, Kaylnn and Rhie, Sandy Jeong},
title = {Real-World Antidepressant Prescribing Patterns and Comparative Safety Outcomes of Commonly Prescribed Antidepressants in Patients with Depressive Disorder: A Multicenter OMOP-CDM Study},
journal = {Pharmaceuticals},
year = {2026},
volume = {19},
number = {9},
pages = {1332},
doi = {10.3390/ph19091332}
}
EUVIMED